The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
You are here Home Guidance and resources Sponsors Mayne Pharma International Pty Ltd Regulatory activities for this sponsor. Listen Print Share Loading... Type ARTG (1) (-) ARTG (1) Cancellation by sponsor (1) Cancellation by sponsor (1) Prescription medicine registration (1) Prescription medicine registration (1) Date 2024 (1) (-) 2024 (1) 2023 (2) 2023 (2) 2022 (5) 2022 (5) 2021 (1) 2021 (1) 2020 (2) 2020 (2) 2019 (2) 2019 (2) 2018 (4) 2018 (4) 2017 (3) 2017 (3) 2015 (2) 2015 (2) 2014 (3) 2014 (3) 2013 (3) 2013 (3) 2012 (4) 2012 (4) 2010 (1) 2010 (1) 2009 (1) 2009 (1) 2007 (1) 2007 (1) 2004 (2) 2004 (2) 2002 (1) 2002 (1) 1999 (1) 1999 (1) 1998 (1) 1998 (1) 1996 (6) 1996 (6) 1994 (3) 1994 (3) 1991 (10) 1991 (10) Show more Search Filters applied:ARTG2024Clear all Sponsor content1 result(s) found, displaying 1 to 1 MAYNE PHARMA 5FU fluorouracil 5% w/w cream tube (394830) 6 March 2024 ARTG Australian Register of Therapeutic Goods (ARTG) information for MAYNE PHARMA 5FU fluorouracil 5% w/w cream tube.
MAYNE PHARMA 5FU fluorouracil 5% w/w cream tube (394830) 6 March 2024 ARTG Australian Register of Therapeutic Goods (ARTG) information for MAYNE PHARMA 5FU fluorouracil 5% w/w cream tube.